Company Tiziana Life Sciences PLC Nasdaq
Equities
TLSA
US88875G1013
Biotechnology & Medical Research
Business Summary
Number of employees: 9
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 98-02-10 |
Keeren Shah
DFI | Director of Finance/CFO | 47 | - |
Vaseem Palejwala
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Matthew Davis
COO | Chief Operating Officer | - | 22-06-30 |
Paul Spencer
IRC | Investor Relations Contact | - | 22-11-30 |
William Clementi
PRN | Corporate Officer/Principal | - | 23-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Brancaccio
BRD | Director/Board Member | 76 | 20-06-30 |
Willy Simon
BRD | Director/Board Member | 72 | 15-10-31 |
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 98-02-10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 194,612,289 | 64,188,859 ( 32.98 %) | 0 | 32.98 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
ACCUSTEM SCIENCES, INC. 11.80% | 1,337,970 | 11.80% | 445,544 $ |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+33.63% | 50.93B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B |